Prime minister NARENDRA MODI likely to have big announcement on his speech from red fort on independence day . sources informed to NEWS MANTRA that a special team coordinating from PMO taking all update on COVID vaccine development .
India’s COVID-19 recoveries have crossed the historic peak of 1.5 million today. Recovery of 15,35,743 patients has been made possible because of the policy of TESTING aggressively, TRACKING comprehensively & TREATING efficiently. Better ambulance services, focus on Standard of Care and use of non-invasive oxygen have given the desired results.With the highest ever single day recoveries of 54,859 in the last 24 hours, the Recovery Rate amongst the COVID-19 patients has scaled another high of almost 70%.The record high recoveries have ensured that the actual caseload of the country viz. the active cases has reduced and currently comprises only 28.66% of the total positive cases. India has posted more than 9 lakh recoveries than the active cases (6,34,945).The coordinated efforts of Centre and State/UT governments on early detection through aggressive testing and efficient clinical management of hospitalized cases have shown results with continuously regressing Case Fatality Rate.
Meanwhile The Expert Committee on vaccine administration under the chairmanship of NITI Aayog member Dr V K Paul will meet on Wednesday to consider the logistics and ethical aspects of procurement and administration of COVID-19 vaccine, said the Union Ministry of Health and Family Welfare.
The Committee will engage with all the stakeholders including state governments and vaccine manufacturers.
“The Expert Committee on Vaccine Administration under the chairmanship of Dr V K Paul, NITI Aayog will meet on 12th August to consider logistics & ethical aspects of procurement & administration of #COVID19 vaccine,” the Ministry tweeted.
“The Committee will engage with all the stakeholders including State governments and vaccine manufacturers,” it said in another tweet.
According to the Indian Council of Medical Research (ICMR), three Indian COVID-19 vaccines are in different phases of clinical testing at present.
“At the present moment, we have three Indian vaccines that are in different phases of clinical testing. The 2 vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine,” said top ICMR scientist (Prof) Balram Bhargava.
“Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites,” he added.
India’s COVID-19 count has crossed 22 lakh-mark including 6,34,945 active cases, 15,35,744 cured/discharged/migrated while the cumulative toll reached 44,386.